These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 26661252)
1. Cilostazol ameliorates collagenase-induced cerebral hemorrhage by protecting the blood-brain barrier. Takagi T; Imai T; Mishiro K; Ishisaka M; Tsujimoto M; Ito H; Nagashima K; Matsukawa H; Tsuruma K; Shimazawa M; Yoshimura S; Kozawa O; Iwama T; Hara H J Cereb Blood Flow Metab; 2017 Jan; 37(1):123-139. PubMed ID: 26661252 [TBL] [Abstract][Full Text] [Related]
2. Protective effects of cilostazol against hemorrhagic stroke: Current and future perspectives. Takagi T; Hara H J Pharmacol Sci; 2016 Jul; 131(3):155-61. PubMed ID: 27381422 [TBL] [Abstract][Full Text] [Related]
3. The phosphodiesterase III inhibitor cilostazol protects the brain microvasculature from collagenase injury. Imai T; Matsukawa H; Takagi T; Tsuruma K; Shimazawa M; Hara H Neuroreport; 2017 Jul; 28(10):555-560. PubMed ID: 28574925 [TBL] [Abstract][Full Text] [Related]
4. [Protective effects of cilostazol against transient focal cerebral ischemia and hemorrhagic transformation]. Ishiguro M; Hara H Yakugaku Zasshi; 2011 Apr; 131(4):513-21. PubMed ID: 21467790 [TBL] [Abstract][Full Text] [Related]
5. Cilostazol ameliorates warfarin-induced hemorrhagic transformation after cerebral ischemia in mice. Kitashoji A; Egashira Y; Mishiro K; Suzuki Y; Ito H; Tsuruma K; Shimazawa M; Hara H Stroke; 2013 Oct; 44(10):2862-8. PubMed ID: 23881959 [TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase-III inhibitor prevents hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA. Ishiguro M; Mishiro K; Fujiwara Y; Chen H; Izuta H; Tsuruma K; Shimazawa M; Yoshimura S; Satoh M; Iwama T; Hara H PLoS One; 2010 Dec; 5(12):e15178. PubMed ID: 21151895 [TBL] [Abstract][Full Text] [Related]
7. Pyruvate and cilostazol protect cultured rat cortical pericytes against tissue plasminogen activator (tPA)-induced cell death. Kim HN; Kim TY; Yoon YH; Koh JY Brain Res; 2015 Dec; 1628(Pt B):317-326. PubMed ID: 26111647 [TBL] [Abstract][Full Text] [Related]
8. Cilostazol reduces blood brain barrier dysfunction, white matter lesion formation and motor deficits following chronic cerebral hypoperfusion. Edrissi H; Schock SC; Cadonic R; Hakim AM; Thompson CS Brain Res; 2016 Sep; 1646():494-503. PubMed ID: 27350079 [TBL] [Abstract][Full Text] [Related]
9. Anti-depressant effects of phosphodiesterase 3 inhibitor cilostazol in chronic mild stress-treated mice after ischemic stroke. Kim YR; Kim HN; Hong KW; Shin HK; Choi BT Psychopharmacology (Berl); 2016 Mar; 233(6):1055-66. PubMed ID: 26686236 [TBL] [Abstract][Full Text] [Related]
10. Cilostazol attenuates ischemia-reperfusion-induced blood-brain barrier dysfunction enhanced by advanced glycation endproducts via transforming growth factor-β1 signaling. Takeshita T; Nakagawa S; Tatsumi R; So G; Hayashi K; Tanaka K; Deli MA; Nagata I; Niwa M Mol Cell Neurosci; 2014 May; 60():1-9. PubMed ID: 24472843 [TBL] [Abstract][Full Text] [Related]
11. Cilostazol protects against hemorrhagic transformation in mice transient focal cerebral ischemia-induced brain damage. Nonaka Y; Tsuruma K; Shimazawa M; Yoshimura S; Iwama T; Hara H Neurosci Lett; 2009 Mar; 452(2):156-61. PubMed ID: 19383431 [TBL] [Abstract][Full Text] [Related]
12. Long-term cilostazol administration ameliorates memory decline in senescence-accelerated mouse prone 8 (SAMP8) through a dual effect on cAMP and blood-brain barrier. Yanai S; Toyohara J; Ishiwata K; Ito H; Endo S Neuropharmacology; 2017 Apr; 116():247-259. PubMed ID: 27979612 [TBL] [Abstract][Full Text] [Related]
13. Cilostazol strengthens barrier integrity in brain endothelial cells. Horai S; Nakagawa S; Tanaka K; Morofuji Y; Couraud PO; Deli MA; Ozawa M; Niwa M Cell Mol Neurobiol; 2013 Mar; 33(2):291-307. PubMed ID: 23224787 [TBL] [Abstract][Full Text] [Related]
14. P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats. Zhao H; Zhang X; Dai Z; Feng Y; Li Q; Zhang JH; Liu X; Chen Y; Feng H Sci Rep; 2016 Mar; 6():23286. PubMed ID: 26980524 [TBL] [Abstract][Full Text] [Related]
15. The phosphodiesterase III inhibitor cilostazol ameliorates ethanolinduced endothelial dysfunction. Takagi T; Mishiro K; Shimazawa M; Yoshimura S; Iwama T; Hara H Curr Neurovasc Res; 2014; 11(4):302-11. PubMed ID: 25219661 [TBL] [Abstract][Full Text] [Related]
16. Cilostazol inhibits the redistribution of the actin cytoskeleton and junctional proteins on the blood-brain barrier under hypoxia/reoxygenation. Torii H; Kubota H; Ishihara H; Suzuki M Pharmacol Res; 2007 Feb; 55(2):104-10. PubMed ID: 17157525 [TBL] [Abstract][Full Text] [Related]
17. Cilostazol reduces the risk of hemorrhagic infarction after administration of tissue-type plasminogen activator in a murine stroke model. Kasahara Y; Nakagomi T; Matsuyama T; Stern D; Taguchi A Stroke; 2012 Feb; 43(2):499-506. PubMed ID: 22033992 [TBL] [Abstract][Full Text] [Related]
18. Cilostazol, a phosphodiesterase inhibitor, prevents no-reflow and hemorrhage in mice with focal cerebral ischemia. Hase Y; Okamoto Y; Fujita Y; Kitamura A; Nakabayashi H; Ito H; Maki T; Washida K; Takahashi R; Ihara M Exp Neurol; 2012 Jan; 233(1):523-33. PubMed ID: 22173318 [TBL] [Abstract][Full Text] [Related]
19. Neurovascular protection of cilostazol in stroke-prone spontaneous hypertensive rats associated with angiogenesis and pericyte proliferation. Omote Y; Deguchi K; Kono S; Liu N; Liu W; Kurata T; Yamashita T; Ikeda Y; Abe K J Neurosci Res; 2014 Mar; 92(3):369-74. PubMed ID: 24375726 [TBL] [Abstract][Full Text] [Related]
20. Cilostazol, not aspirin, reduces ischemic brain injury via endothelial protection in spontaneously hypertensive rats. Oyama N; Yagita Y; Kawamura M; Sugiyama Y; Terasaki Y; Omura-Matsuoka E; Sasaki T; Kitagawa K Stroke; 2011 Sep; 42(9):2571-7. PubMed ID: 21799161 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]